A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.
about
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin AHerkinorin analogues with differential beta-arrestin-2 interactionsStandard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethersStudies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonistSynthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-positionNeuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AChemical methods for the synthesis and modification of neoclerodane diterpenesSalvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptorsOpioid receptors and legal highs: Salvia divinorum and Kratom.Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analoguesOpioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin AConvenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.Semisynthetic neoclerodanes as kappa opioid receptor probes.Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans.Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.Neoclerodanes as atypical opioid receptor ligandsSalvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.Autoxidation of salvinorin A under basic conditions.LC-MS/MS quantification of salvinorin A from biological fluids.Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in RatsMichael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonistsNovel neoclerodane diterpene derivatives from the smoke of salvinorin A.Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.In vitro stability and metabolism of salvinorin A in rat plasma.Salvia divinorum: toxicological aspects and analysis in human biological specimens
P2860
Q24647224-C6967A74-E68D-4640-8A77-6A0658A85658Q24649793-4EFA7805-3593-4B37-A389-3F8EEE163E99Q24651427-84F76F3A-6CFF-4936-B7ED-C72650732CC9Q24656126-152879F1-B148-4120-82E9-9BFF03D6F76EQ24681800-0890F50E-0227-4D15-ABB0-05EE769B8078Q30467220-344ED748-01F3-49C7-80D4-B22C525310EFQ34296387-2118CB62-51B5-48B8-BF8A-2845402C8EC8Q34302349-3FC72C99-C091-4CBE-B267-350F2CC236A7Q34401390-40F13013-9801-4C35-A31C-7685471BE5B7Q34510909-FC41B054-E635-4EBD-9ACA-73584696E509Q34747694-9A2EB7A8-A2A8-4F09-ADF2-642D059A9987Q34796464-746F1764-F755-44D5-BDCD-5D8E619C4C92Q34851195-A3683513-05C5-4C76-B7EF-03BE9BFC58F8Q35840042-3ED627AF-84C7-4B2E-8A9F-9D554C2DD9E3Q35867490-8CA44A6A-CE26-4BF9-8796-02215E161F6CQ35935443-17AA7BEF-705D-4B2D-AC82-FF31827FCB65Q36766665-C6A623E0-6D1C-4E8C-A5D1-70BF26701EAFQ36873376-B716493E-9965-4380-9CE3-8F500608647EQ36899819-36A55616-EFFC-4DBB-9332-4B7FA929DB2AQ37349384-A9E52D3E-D9D2-4D59-99A3-BE7D007BE99AQ37422833-5627E7B4-BDAE-45C8-83BF-818A3C4E318DQ37451366-04A583E6-0467-4B66-9B4C-8E0CEEB9C6C8Q37458190-7A2813B3-5C96-4A35-90BD-EF203A1794D0Q42141072-781E1218-78CC-4A41-9EF1-234A7ECEE02EQ42142560-6DAF482F-5718-4928-B31D-8EBFAD17AD0AQ42286399-E8FAC0B2-A366-4211-B0F0-AECC18CBCD6DQ44344643-EDD6E07D-90C8-4722-899B-293C38297B3BQ46091354-E01281D4-86F4-43DF-8497-E9D534B763F6Q57888900-68B079E8-819C-47C4-A65C-89990F30378E
P2860
A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@ast
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@en
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@nl
type
label
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@ast
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@en
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@nl
prefLabel
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@ast
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@en
A facile method for the prepar ...... s of [2,2,2-2H3]-salvinorin A.
@nl
P2093
P1476
A facile method for the prepar ...... is of [2,2,2-2H3]-salvinorin A
@en
P2093
Daryl J Murry
Kenneth G Holden
Thomas E Prisinzano
Wayne W Harding
P304
P356
10.1016/J.BMCL.2004.07.081
P407
P577
2004-10-01T00:00:00Z